Complications - [c] Cardiac Disease and Lipid Therapy

Table 27 shows the analysis of the Cholesterol levels [Target ≤ 4 mmol/l] and Lipid Therapy [LipRx] status of individuals reported to have ever had a Myocardial Infarct or CABG/Angioplasty. Of 623 individuals, 34.8% were above target despite 90.8% receiving Lipid Therapy [with mean Total Cholesterol 4.8 mmol/l and 9.2% not on Lipid Rx at all!].

Table 27 Cardiac Disease and Anti-Lipid Rx [Adult Forms Only]

Any Infarct, CABG or Stroke

Chol	LipRx	N	% in Category	%	Mean Chol	Mean HDL	Mean TG	Mean LDL
Chol >4	No	20	9.2%		5.0	1.2	1.8	2.8
	Yes	197	90.8%		4.8	1.2	2.4	2.6
Total		217		34.8%
Chol ≤4	No	22	5.4%		3.5	1.2	1.2	1.7
	Yes	384	94.6%		3.3	1.0	1.6	1.5
Total		406		65.2%
		623		100.0%

Cardiac Disease is: the occurrence of CABG / Angioplasty and/or Myocardial Infarction, either in the past 12 months or previously [ie Any CABG or Infarct].